Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Researchers at Oxford University have been awarded a £6 million grant for their cutting-edge research programme on finding drug targets for Parkinson's Disease.

This new funding builds on an initial £5M investment from Parkinson’s UK to researchers at the Oxford Parkinson’s Disease Centre (OPDC) in 2010.

One in 500 people in Oxfordshire have Parkinson's – a neurological condition which can leave people struggling to walk, speak and sleep, and which has no cure.

By 2020 the multidisciplinary team at Oxford hopes to use the £6 million to find new drugs to slow, or even stop Parkinson's, using a 'brain cell bank' they have developed to identify promising new drug targets. They also want to improve how to diagnose and monitor Parkinson's using new technology, such as smartphone apps.

In the last five years, the team has developed one of the largest studies of people living with Parkinson's anywhere in the world, leading to progress in understanding why brain cells die and in detecting early changes in patients before full symptoms occur. Working with Thames Valley patients the team have created a tool to detect early stage Parkinson's with 85% accuracy using brain imaging.

Professor Richard-Wade Martins, lead researcher at the OPDC, said of receiving the funding: 'In the last five years we've made remarkable progress. We've built a study integrating work in the clinic and the laboratory like nowhere else in the world. Alongside this, our program to change cells from patients' skin into brain cells using cutting-edge stem cell technology has allowed us to gain completely new insights about Parkinson's and how it develops.

We’re delighted the new funding from Parkinson’s UK will secure the future of this and other vital projects.'

Read more

                   

Similar stories

Vladyslav Vyazovskiy elected Vice President of the European Sleep Research Society

Congratulations are in order to Professor Vladyslav Vyazovskiy on his appointment as Vice President (Basic) of the European Sleep Research Society (ESRS).

New evidence for how our brains handle surprise

A new study from the Bruno Group is challenging our perceptions of how the different regions of the cerebral cortex function. A group of ‘quiet’ cells in the somatosensory cortex that rarely respond to touch have been found to react mainly to surprising circumstances. The results suggest their function is not necessarily driven by touch, but may indicate an important and previously unidentified role across all the major cortices.

Professor Dame Sue Black to deliver 2022 Christmas Lectures

In the 2022 Christmas Lectures from the Royal Institution, DPAG's Visiting Professor of Forensic Anatomy Dame Sue Black will share secrets of forensic science.

Inside the Wade-Martins Lab for World Alzheimer’s Day 2022

This week DPAG marked World Alzheimer's Day, which took place on Wednesday 21 September 2022, with an inside look into the Wade-Martins Laboratory.

Kaitlyn Dennis to receive the William C Stanley Early Investigator Award

Congratulations are in order for DPhil student Kaitlyn Dennis, who has been awarded the William C Stanley Early Investigator Award. The award highlights the scientific accomplishments of promising young researchers and is a major focus of the Annual Meeting of the Society for Heart and Vascular Metabolism.